Q2 2012

Filed Aug 20, 2012 · 10-Q · 51 days after period end · 0001469709-12-000212

Q2 2012 · 10-Q

Revenue

$8.09K

no prior Q2 2011 on file

Net Income

-$430.61K

no prior Q2 2011 on file

EPS Diluted

-$0.01

no prior Q2 2011 on file

Operating Income-$395,661—

Operating Cash Flow

Same quarter

no prior Q2 2011 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2012 · filed Aug 20, 2012 · 51 d after period end

Endonovo Therapeutics, Inc. · CIK 1528172 · Engraved from SEC EDGAR